X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Glaxosmithkline Pharmaceuticals Ltd.
BSE CODE: 500660   |   NSE CODE: GLAXO   |   ISIN CODE : INE159A01016   |   03-May-2024 Hrs IST
BSE NSE
Rs. 2093.85
-9.7 ( -0.46% )
 
Prev Close ( Rs.)
2103.55
Open ( Rs.)
2105.00
 
High ( Rs.)
2144.55
Low ( Rs.)
2078.40
 
Volume
8701
Week Avg.Volume
7432
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 2095.35
-6.4 ( -0.3% )
 
Prev Close ( Rs.)
2101.75
Open ( Rs.)
2122.00
 
High ( Rs.)
2145.00
Low ( Rs.)
2078.10
 
Volume
101606
Week Avg.Volume
134214
 
52 WK High-Low Range(Rs.)
1241.15
2524
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)35.70  22.23  16.92  6.50  25.11  
   CEPS(Rs)39.58  26.25  21.56  11.38  27.98  
   DPS(Rs)32.00  90.00  30.00  40.00  20.00  
   Book NAV/Share(Rs)103.58  158.06  88.37  108.62  126.47  
   Tax Rate(%)27.35  51.31  36.75  65.88  35.91  
Margin Ratios          
   Core EBITDA Margin(%)22.63  21.39  19.16  19.58  19.39  
   EBIT Margin(%)23.61  21.94  14.64  9.78  21.23  
   Pre Tax Margin(%)23.56  21.89  14.53  9.59  21.21  
   PAT Margin (%)17.12  10.66  9.19  3.27  13.60  
   Cash Profit Margin (%)18.98  12.59  11.71  5.73  15.15  
Performance Ratios          
   ROA(%)15.70  10.04  9.53  2.04  5.53  
   ROE(%)27.29  18.04  17.18  5.53  20.15  
   ROCE(%)37.66  37.15  27.37  16.51  31.45  
   Asset Turnover(x)0.92  0.94  1.04  0.62  0.41  
   Sales/Fixed Asset(x)5.69  5.93  3.04  3.34  6.48  
   Working Capital/Sales(x)3.07  1.77  4.64  4.46  5.83  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.18  0.17  0.33  0.30  0.15  
   Receivable days20.54  21.73  18.45  11.96  15.60  
   Inventory Days49.10  53.51  58.87  52.62  57.56  
   Payable days142.20  141.33  117.18  105.65  122.09  
Valuation Parameters          
   PER(x)37.10  74.81  85.11  191.68  51.77  
   PCE(x)33.46  63.34  66.80  109.45  46.46  
   Price/Book(x)12.78  10.52  16.30  11.46  10.28  
   Yield(%)2.42  5.41  2.08  3.21  1.54  
   EV/Net Sales(x)6.62  7.99  7.96  6.21  6.67  
   EV/Core EBITDA(x)23.62  30.88  32.83  27.21  29.47  
   EV/EBIT(x)25.51  33.13  50.89  60.91  31.41  
   EV/CE(x)6.66  5.70  7.76  6.63  2.68  
   M Cap / Sales6.97  8.76  8.36  6.54  7.04  
Growth Ratio          
   Net Sales Growth(%)-0.04  10.17  -9.43  3.07  8.94  
   Core EBITDA Growth(%)8.28  17.53  -3.81  3.96  25.98  
   EBIT Growth(%)7.58  69.77  38.90  -50.50  22.61  
   PAT Growth(%)60.58  31.35  160.50  -74.13  20.85  
   EPS Growth(%)60.58  31.35  160.50  -74.13  -39.58  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)1.87  2.19  1.51  1.75  1.19  
   Quick Ratio(x)1.54  1.89  1.11  1.27  1.02  
   Interest Cover(x)460.68  389.70  129.34  51.90  1198.38  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00